- Investing Ideas
- Belgian Pharmaceuticals & Biotech Most Popular Stocks
Belgian Pharmaceuticals & Biotech Most Popular Stocks
Results
7
Most Popular Stocks on the market
7 companies
argenx
Market Cap: €47.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€761.20
7D
-6.3%
1Y
58.3%
UCB
Market Cap: €44.8b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€232.50
7D
-8.4%
1Y
36.2%
Financière de Tubize
Market Cap: €9.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€203.20
7D
-6.1%
1Y
51.0%
Hyloris Pharmaceuticals
Market Cap: €129.6m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.42
7D
0.9%
1Y
-28.9%
Celyad Oncology
Market Cap: €11.0m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.25
7D
9.6%
1Y
-29.8%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-13.0%
Oxurion
Market Cap: €248.3k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0026
7D
-7.1%
1Y
-89.5%